BCByoungsan Choi

Byoungsan Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Byoungsan Choi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Dae Hee Lee

    Proteina Co. Ltd., Seoul, Republic of Korea

    1 shared publication
  • Gee Sung Eun

    School of Biological Sciences and Institute for Molecular Biology and Genetics, Seoul National University, Seoul, Republic of Korea

    1 shared publication
  • Minkwon Cha

    Department of Physics, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea

    1 shared publication
  • Muhammad Ehsan

    Department of Bionanotechnology, Hanyang University, Ansan, Republic of Korea

    1 shared publication
  • Pil Seok Chae

    Department of Bionanotechnology, Hanyang University, Ansan, Republic of Korea

    1 shared publication
  • Seul Lee

    Proteina Co. Ltd., Seoul, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Single-molecule functional anatomy of endogenous HER2-HER3 heterodimers

    by Byoungsan Choi, Minkwon Cha, Gee Sung Eun, Dae Hee Lee, Seul Lee, Muhammad Ehsan, Pil Seok Chae, Won Do Heo, YongKeun Park, Tae-Young Yoon

    Human epidermal growth factor receptors (HERs) are the primary targets of many directed cancer therapies. However, the reason a specific dimer of HERs generates a stronger proliferative signal than other permutations remains unclear. Here, we used single-molecule immunoprecipitation to develop a biochemical assay for endogenously-formed, entire HER2-HER3 heterodimers. We observed unexpected, large conformational fluctuations in juxta-membrane and kinase domains of the HER2-HER3 heterodimer. Nevertheless, the individual HER2-HER3 heterodimers catalyze tyrosine phosphorylation at an unusually high rate, while simultaneously interacting with multiple copies of downstream signaling effectors. Our results suggest that the high catalytic rate and multi-tasking capability make a concerted contribution to the strong signaling potency of the HER2-HER3 heterodimers.